Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.3
2.8
Journals
Current Oncology
Announcements
share announcement

Announcements

13 September 2024
Current Oncology | Blood Cancer Awareness Month


Blood Cancer Awareness Month in September is a significant global initiative aimed at increasing awareness surrounding blood cancer, its symptoms, and the profound impact it has. By enhancing early detection, advocating for prioritization by policymakers, and fostering a sense of community for individuals affected by blood cancer, this campaign strives to make a meaningful difference in the fight against this disease. We would like to take this opportunity to express our gratitude to all of the researchers who have contributed to this field. In particular, we would like to share some of the innovative research findings in the related fields, published in Current Oncology (ISSN: 1718-7729). We hope this announcement will provide useful information for this field.

“A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature”
by Adrian J. M. Bailey, Aidan M. Kirkham, Madeline Monaghan, Risa Shorr, C. Arianne Buchan, Christopher Bredeson and David S. Allan
Curr. Oncol. 2022, 29(1), 337-349; https://doi.org/10.3390/curroncol29010030  
Available online: https://www.mdpi.com/1718-7729/29/1/30

“Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series”
by Göran Ramin Boeckel, Silke Dorothea Hölscher, Christin Bürger, Torid Jacob, Carolin Krekeler, Evgenii Shumilov, Christian Reicherts, Annalen Bleckmann, Georg Lenz, Richard Vollenberg et al.
Curr. Oncol. 2022, 29(4), 2312-2325; https://doi.org/10.3390/curroncol29040188  
Available online: https://www.mdpi.com/1718-7729/29/4/188

“The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review”
by Adam Suleman, Abi Vijenthira, Alejandro Berlin, Anca Prica and Danielle Rodin
Curr. Oncol. 2022, 29(2), 892-900; https://doi.org/10.3390/curroncol29020076  
Available online: https://www.mdpi.com/1718-7729/29/2/76

“Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy”
by Manlio Mencoboni, Vincenzo Fontana, Azzurra Damiani, Antonino Spitaleri, Alessandro Raso, Luigi Carlo Bottaro, Giovanni Rossi, Luciano Canobbio, Antonella La Camera, Rosa Angela Filiberti et al.
Curr. Oncol. 2022, 29(5), 3364-3374; https://doi.org/10.3390/curroncol29050273  
Available online: https://www.mdpi.com/1718-7729/29/5/273

“Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada”
by John Kuruvilla, Emmanuel M. Ewara, Julia Elia-Pacitti, Ryan Ng, Maria Eberg, Atif Kukaswadia and Arushi Sharma
Curr. Oncol. 2023, 30(5), 4663-4676; https://doi.org/10.3390/curroncol30050352  
Available online: https://www.mdpi.com/1718-7729/30/5/352

“Estimating the Associated Burden of Illness and Healthcare Utilization of Newly Diagnosed Patients Aged ≥65 with Mantle Cell Lymphoma (MCL) in Ontario, Canada”
by Peter Anglin, Julia Elia-Pacitti, Maria Eberg, Sergey Muratov, Atif Kukaswadia, Arushi Sharma and Emmanuel M. Ewara
Curr. Oncol. 2023, 30(6), 5529-5545; https://doi.org/10.3390/curroncol30060418  
Available online: https://www.mdpi.com/1718-7729/30/6/418

“Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse”
by Parva Bhatt, Colin Kloock and Raymond Comenzo
Curr. Oncol. 2023, 30(2), 2322-2347; https://doi.org/10.3390/curroncol30020179  
Available online: https://www.mdpi.com/1718-7729/30/2/179

“Vitamin D and Multiple Myeloma: A Scoping Review”
by Naghmeh Mirhosseini, Athanasios Psihogios, Meagan D. McLaren and Dugald Seely
Curr. Oncol. 2023, 30(3), 3263-3276; https://doi.org/10.3390/curroncol30030248  
Available online: https://www.mdpi.com/1718-7729/30/3/248

You are welcome to submit relevant papers to the journal Current Oncology. If you have any questions, feel free to contact us.

Current Oncology Editorial Office

More News...
Back to TopTop